Clincosm LogoSign in Get a demo

non hodgkin lymphoma

Showing NaN - NaN of 9
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU

Not yet recruiting
  • Non Hodgkin Lymphoma
  • Long-term Follow-Up
  • Stanford, California
  • +4 more
Oct 30, 2023

Non Hodgkin Lymphoma Trial in Australia, United Kingdom, United States (Magrolimab, Rituximab, Gemcitabine)

Active, not recruiting
  • Non Hodgkin Lymphoma
  • Birmingham, Alabama
  • +19 more
Dec 8, 2022

Hodgkin Lymphoma, Non Hodgkin Lymphoma Trial in United States (AB-205, Placebo)

Recruiting
  • Hodgkin Lymphoma
  • Non Hodgkin Lymphoma
  • AB-205
  • Placebo
  • Duarte, California
  • +20 more
Aug 2, 2022

Follicular Lymphoma (FL), Non Hodgkin Lymphoma, Marginal Zone Lymphoma Trial in Worldwide (Zandelisib (ME-401))

Recruiting
  • Follicular Lymphoma (FL)
  • +2 more
  • Zandelisib (ME-401)
  • Tucson, Arizona
  • +115 more
Mar 8, 2022

Non Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma Trial in Boston (Anakinra, Axicabtagene

Recruiting
  • Non Hodgkin Lymphoma
  • +5 more
  • Boston, Massachusetts
  • +1 more
Oct 28, 2021

GVHD, AML, ALL Trial in Boston (FLUDARABINE, CYCLOPHOSPHAMIDE, TBI)

Recruiting
  • GVHD
  • +15 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Sep 30, 2021

Patients Previously Treated With a Juno CAR T-Cell Product

Terminated
  • Non Hodgkin Lymphoma
  • +5 more
  • JCAR017
  • JCARH125
  • Duarte, California
  • +1 more
Apr 30, 2020

Non Hodgkin Lymphoma, High-grade B-cell Lymphoma, Diffuse Large B Cell Lymphoma Trial in Boston (Cyclophosphamide, Alemtuzumab)

Terminated
  • Non Hodgkin Lymphoma
  • +2 more
  • Boston, Massachusetts
  • +1 more
Jan 10, 2019

Non Hodgkin Lymphoma Trial in Worldwide (enzastaurin, )

Completed
Has Results
  • Non Hodgkin Lymphoma
  • Anchorage, Alaska
  • +152 more
Sep 6, 2018